ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BNR Burning Rock Biotech Ltd

0.35
0.00 (0.00%)
13 May 2024 - Closed
Delayed by 15 minutes
Name Symbol Market Type
Burning Rock Biotech Ltd LSE:BNR London Depository Receipt
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  0.00 0.00% 0.35 0 01:00:00

Blenheim Natural Resources PLC Result of General Meeting (2542W)

07/02/2017 1:45pm

UK Regulatory


Burning Rock Biotech (LSE:BNR)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Burning Rock Biotech Charts.

TIDMBNR

RNS Number : 2542W

Blenheim Natural Resources PLC

07 February 2017

7 February 2017

Blenheim Natural Resources Plc

("Blenheim" or the "Company")

Result of General Meeting

Blenheim is pleased to announce that at the Company's General Meeting held earlier today, all resolutions were duly passed.

As a result, shareholders have granted the directors the authority to allot and issue, inter alia, 214,285,714 ordinary shares of 0.1 pence each in the capital of the Company ("Ordinary Shares") and 214,285,714 warrants over Ordinary Shares, pursuant to the conditional placing announced on 18 January 2017. The directors have also been granted the authority to issue 10,714,286 warrants over Ordinary Shares to Cornhill Capital Limited, the Company's joint broker. Further, shareholders have granted the directors the authority to allot and issue up to 60,000,000 Ordinary Shares as partial consideration, should the Company exercise its option to acquire a 30 per cent interest in the Dieba exploration permit (as announced on 18 January 2017).

The Directors have also been granted authority to buy back and cancel all of the deferred shares in issue for an aggregate consideration of GBP1 at any time prior to 31 December 2017.

Application has been made for the 214,285,714 Ordinary Shares pursuant to the placing, which rank pari passu with the Company's existing issued Ordinary Shares, to be admitted to trading on the AIM Market of the London Stock Exchange ("AIM"). Dealings on AIM are expected to commence at 8:00 a.m. on or around 8 February 2017 ("Admission").

Total Voting Rights

Following Admission, the issued share capital of the Company will comprise 398,576,614 Ordinary Shares with voting rights attached (one vote per share). The Company does not hold any shares in treasury. This figure of 398,576,614 may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

For further information please contact:

 
                       Blenheim Natural          +44 (0) 1622 
Chris Ells              Resources Plc             844601 
 
Colin Aaronson/Jamie   Grant Thornton UK 
 Barklem/ Daniel        LLP                      +44 (0) 20 7383 
 Bush                   (Nominated Adviser)       5100 
 
                       SI Capital Ltd (Joint 
Nick Emerson            Broker)                  +44 (0)1483 413500 
                       Peterhouse Corporate 
Lucy Williams /         Finance Limited (Joint   +44 (0) 20 7469 
 Duncan Vasey           Broker)                   0932 
                       Cornhill Capital          +44 (0) 20 7710 
Colin Rowbury           Limited (Joint Broker)    9610 
 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

This information is provided by RNS

The company news service from the London Stock Exchange

END

ROMXDLFBDLFZBBZ

(END) Dow Jones Newswires

February 07, 2017 08:45 ET (13:45 GMT)

1 Year Burning Rock Biotech Chart

1 Year Burning Rock Biotech Chart

1 Month Burning Rock Biotech Chart

1 Month Burning Rock Biotech Chart

Your Recent History

Delayed Upgrade Clock